16:11 19/01/2026
icon facebook icon twitter icon pinterest
Nguồn tham khảo
  1. Van Kleef, L. A., Choi, H. S., Brouwer, W. P., Hansen, B. E., Patel, K., De Man, R. A., Janssen, H. L., De Knegt, R. J., & Sonneveld, M. J. (2021). Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B. JHEP Reports, 3(5), 100350. https://doi.org/10.1016/j.jhepr.2021.100350
  2. Chen, Y., Fang, W., Wang, C., Kao, T., Chang, Y., Yang, H., Wu, C., Sun, Y., & Chen, W. (2018). Increased body fat percentage in patients with hepatitis B and C virus infection. PLoS ONE, 13(7), e0200164. https://doi.org/10.1371/journal.pone.0200164
Chủ đề:
Banner ECO Pharma 15 năm

ĐẶT CÂU HỎI